Please login to the form below

Not currently logged in
Email:
Password:

financial results

This page shows the latest financial results news and features for those working in and with pharma, biotech and healthcare.

Hardy returns to Genentech as CEO

Hardy returns to Genentech as CEO

He also insisted that the decision is completely unrelated to its financial and business performance, with Q4 results expected to be announced on 5 February.

Latest news

  • Credit Score Credit Score

    Failing to provide the necessary financial proof results in, very simply, a denial of your transplant. ... We tell ourselves that we are not using financial stability as a gateway to care, but we are.

  • Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity

    Novo Nordisk is claiming a 14% share of the new-to-brand prescription market with Ozempic, and says “initial feedback from prescribers and payers is positive” in its first-half results ... Obesity drug dropped. In an R&D update accompanying the

  • The secret of success The secret of success

    How does this relate to the business models of life science companies and the current crop of financial results? ... Well, just as in the competition between species, we can see a distinct polarisation of results.

  • Shire claims EU approval for haemophilia A drug Adynovi Shire claims EU approval for haemophilia A drug Adynovi

    figures for individual haemophilia products in its financial results is estimated to have made around $300m last year - or around 10% of its total franchise.

  • Biosimilars eat into J&J's Remicade sales Biosimilars eat into J&J's Remicade sales

    This is the first set of financial results for J&J since it closed the acquisition of Swiss biotech Actelion, a specialist in pulmonary arterial hypertension (PAH), on June 16.

More from news
Approximately 70 fully matching, plus 111 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    some financial companies to re-emerge as Barbarians.  The 2008 financial crash is a salutary reminder. ... What happens next?    Assuming the deal is completed, DW predicts the new Stada will start to hunt for product and company acquisitions to

  • Deal Watch August 2016 Deal Watch August 2016

    company rather than seeking a short term financial 'fix' to improve its financial results.”. ... In the same way that the asset acquisition deal between AstraZeneca and Pfizer had the financial structure of a licence, so too does the Pfizer acquisition

  • Technology: the missing link in true patient engagement? Technology: the missing link in true patient engagement?

    This comes at a huge financial cost, and results in suboptimal patient outcomes. ... While manual adherence programmes with assigned nurses have yielded positive outcomes, it isn't always possible to provide this widely due to financial and resource

  • Deal Watch April 2016 Deal Watch April 2016

    term financial 'fix' to improve its financial results. ... The deal with Nimbus did not excite investors and they were even less impressed when Gilead reported first quarter results showing sales growth of 4% and full year guidance of $30bn

  • Who tops the pharma list? Who tops the pharma list?

    Chris Ross, with the help of healthcare analysts GlobalData, takes a New Year look at the past, present and future of global pharma, and asks: what’s trending? 

More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest appointments

  • BMS appoints Peter Arduini to board of directors BMS appoints Peter Arduini to board of directors

    Lamberto Andreotti, chairman of BMS, said: “Pete is a confident and engaging leader who has delivered tremendous results throughout his career. ... His commercial, financial and operational experience, along with a deep understanding of healthcare,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics